每年研究成果
每年研究成果
個人檔案
研究專長
Vascular Medicine and Molecular Biology, Diabetes Mellitus, Kidney Disease, Experimental Animal Model Design, New Drug Development
教育/學術資格
PhD, 藥理學, 國立陽明交通大學
指紋
查看啟用 Ting-Ting Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 1 類似的個人檔案
過去五年中的合作和熱門研究領域
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
-
CCL4 contributes to aging related angiogenic insufficiency through activating oxidative stress and endothelial inflammation
Chang, T. T., Lin, L. Y., Chen, C. & Chen, J. W., 8月 2024, 於: Angiogenesis. 27, 3, p. 475-499 25 p.研究成果: Article › 同行評審
開啟存取1 引文 斯高帕斯（Scopus） -
Novel prognostic impact and cell specific role of endocan in patients with coronary artery disease
Lin, L. Y., Chang, T. T., Leu, H. B., Huang, C. C., Wu, T. C., Chou, R. H., Huang, P. H., Yin, W. H., Tseng, W. K., Wu, Y. W., Lin, T. H., Yeh, H. I., Chang, K. C., Wang, J. H., Wu, C. C. & Chen, J. W., 2024, (Accepted/In press) 於: Clinical Research in Cardiology.研究成果: Article › 同行評審
開啟存取 -
Soluble tumor necrosis factor receptor type 1 is an alternative marker of urinary albumin-creatinine ratio and estimated glomerular filtration rate for predicting the decline of renal function in subjects with type 2 diabetes mellitus
Chang, L. H., Chang, T. T., Chu, C. H., Huang, C. C. & Lin, L. Y., 15 5月 2024, 於: Clinica Chimica Acta. 558, 117880.研究成果: Article › 同行評審
開啟存取 -
Correction: CXCL5 suppression recovers neovascularization and accelerates wound healing in diabetes mellitus (Cardiovascular Diabetology, (2023), 22, 1, (172), 10.1186/s12933-023-01900-w)
Chen, C., Lin, L. Y., Chen, J. W. & Chang, T. T., 12月 2023, 於: Cardiovascular Diabetology. 22, 1, 196.研究成果: Comment/debate
開啟存取 -
CXCL5 suppression recovers neovascularization and accelerates wound healing in diabetes mellitus
Chen, C., Lin, L. Y., Chen, J. W. & Chang, T. T., 12月 2023, 於: Cardiovascular Diabetology. 22, 1, 172.研究成果: Article › 同行評審
開啟存取5 引文 斯高帕斯（Scopus）